Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Servicio de Medicina Interna, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
Int J Cardiol. 2019 May 1;282:24-30. doi: 10.1016/j.ijcard.2019.01.014. Epub 2019 Jan 10.
To evaluate the effect of the type of surgical indication on mortality in infective endocarditis (IE) patients who are rejected for surgery.
From January 2008 to December 2016, 2714 patients with definite left-sided IE were attended in the participating hospitals. One thousand six hundred and fifty-three patients (60.9%) presented surgical indications. Five hundred and thirty-eight patients (32.5%) presented surgical indications but received medical treatment alone. The indications for surgery in these patients were uncontrolled infection (366 patients, 68%), heart failure (168 patients, 31.3%) and prevention of embolism (148 patients, 27.6%). One hundred and thirty patients (24.2%) presented more than one indication. The mortality during hospital admission was 60% (323 patients). The in-hospital mortality of patients whose indication for surgery was heart failure, uncontrolled infection or risk of embolism was 75.6%, 61.4% and 54.7%, respectively (p < 0.001). Surgical indications due to heart failure (OR: 3.24; CI 95%: 1.99-5.9) or uncontrolled infection (OR: 1.83; CI 95%: 1.04-3.18) were independently associated with a fatal outcome during hospital admission. Mortality during the first year was 75.4%. The mortality during the first year in patients whose indication for surgery was heart failure, uncontrolled infection or risk of embolism was 85.9%, 76.7% and 72.7%, respectively (p = 0.016). Surgical indication due to heart failure (OR: 3.03; CI 95%: 1.53-5.98) were independently associated with fatal outcome during the first year.
The type of surgical indication is associated with mortality in IE patients who are rejected for surgical intervention.
评估手术适应证类型对因手术禁忌而接受药物治疗的感染性心内膜炎(IE)患者死亡率的影响。
2008 年 1 月至 2016 年 12 月,2714 例确诊为左侧 IE 的患者在参与医院接受治疗。1653 例(60.9%)患者存在手术适应证。538 例(32.5%)患者存在手术适应证,但仅接受药物治疗。这些患者手术的适应证为:感染未得到控制(366 例,68%)、心力衰竭(168 例,31.3%)和预防栓塞(148 例,27.6%)。130 例(24.2%)患者存在不止一个适应证。住院期间死亡率为 60%(323 例)。手术适应证为心力衰竭、感染未得到控制或有栓塞风险的患者住院期间死亡率分别为 75.6%、61.4%和 54.7%(p<0.001)。因心力衰竭(OR:3.24;95%CI:1.99-5.9)或感染未得到控制(OR:1.83;95%CI:1.04-3.18)而存在手术适应证与住院期间的死亡结局独立相关。第 1 年的死亡率为 75.4%。因心力衰竭、感染未得到控制或有栓塞风险而存在手术适应证的患者,第 1 年的死亡率分别为 85.9%、76.7%和 72.7%(p=0.016)。因心力衰竭而存在手术适应证(OR:3.03;95%CI:1.53-5.98)与第 1 年的死亡结局独立相关。
手术适应证类型与因手术禁忌而接受药物治疗的 IE 患者的死亡率相关。